To register or for more information please contact InvestorRelations@indivior.com
Mark Crossley
Chief Executive Officer
Capital Markets Day
December 7th 2022 | New York City and Virtual
Setting out Indivior's roadmap for delivering long-term shareholder value
Indivior is a global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for substance use disorders and other serious mental illnesses. To register for the in-person event, please email InvestorRelations@indivior.com.
Virtual webcast link can be found by accessing the "Event Materials" tab.
Presenters
Please see an overview of the event. More information will be released nearer to the event date
- When: Wednesday, December 7th, 2022 (8:30 AM to 12:30 PM US Eastern)
- What: Investor event setting out Indivior's roadmap for delivering long-term shareholder value
- Where: New York City and Virtual webcast
- Register: For in-person event email InvestorRelations@indivior.com. For virtual participation, please see "Event Materials" tab for link.
- 8:30 - Welcome
- 8:35 - Company Overview & Strategy - Mark Crossley, CEO
- 9:00 - SUBLOCADE® - Richard Simkin, Chief Commercial Officer, Vishal Kalia, SVP, US Treatment Access, Support Programs and Business Insights, Dr. Terry Horton, VP, Patient Insights and Advocacy
- 10:15 - Q&A
- 10:30 - Break
- 10:45 - PERSERIS® - Glenn Tyson, SVP, Sales & Marketing
- 11:10 - R&D Pipeline - Dr. Christian Heidbreder, Chief Scientific Officer
- 11:40 - ESG and Sustainability - Nina DeLorenzo, Chief Global Impact Officer
- 11:55 - Operational Excellence - Ryan Preblick, CFO
- 12:15 - Closing Remarks and Q&A